{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T12:21:11Z","timestamp":1780489271740,"version":"3.54.1"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2019,12,9]],"date-time":"2019-12-09T00:00:00Z","timestamp":1575849600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,12,9]],"date-time":"2019-12-09T00:00:00Z","timestamp":1575849600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Immunol Immunother"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1007\/s00262-019-02435-4","type":"journal-article","created":{"date-parts":[[2019,12,9]],"date-time":"2019-12-09T15:03:06Z","timestamp":1575903786000},"page":"263-273","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Partners in crime: TNF\u03b1-based networks promoting cancer progression"],"prefix":"10.1007","volume":"69","author":[{"given":"Adit","family":"Ben-Baruch","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,12,9]]},"reference":[{"key":"2435_CR1","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.immuni.2019.06.025","volume":"51","author":"FR Greten","year":"2019","unstructured":"Greten FR, Grivennikov SI (2019) Inflammation and cancer: triggers, mechanisms, and consequences. Immunity 51:27\u201341. https:\/\/doi.org\/10.1016\/j.immuni.2019.06.025","journal-title":"Immunity"},{"key":"2435_CR2","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1038\/s41568-018-0006-7","volume":"18","author":"S Maman","year":"2018","unstructured":"Maman S, Witz IP (2018) A history of exploring cancer in context. Nat Rev Cancer 18:359\u2013376. https:\/\/doi.org\/10.1038\/s41568-018-0006-7","journal-title":"Nat Rev Cancer"},{"key":"2435_CR3","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1182\/blood-2011-04-325225","volume":"119","author":"BB Aggarwal","year":"2012","unstructured":"Aggarwal BB, Gupta SC, Kim JH (2012) Historical perspectives on tumor necrosis factor and its superfamily: 25\u00a0years later, a golden journey. Blood 119:651\u2013665. https:\/\/doi.org\/10.1182\/blood-2011-04-325225","journal-title":"Blood"},{"key":"2435_CR4","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1002\/path.4188","volume":"230","author":"JP Waters","year":"2013","unstructured":"Waters JP, Pober JS, Bradley JR (2013) Tumour necrosis factor and cancer. J Pathol 230:241\u2013248. https:\/\/doi.org\/10.1002\/path.4188","journal-title":"J Pathol"},{"key":"2435_CR5","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1038\/nrc2628","volume":"9","author":"F Balkwill","year":"2009","unstructured":"Balkwill F (2009) Tumour necrosis factor and cancer. Nat Rev Cancer 9:361\u2013371. https:\/\/doi.org\/10.1038\/nrc2628","journal-title":"Nat Rev Cancer"},{"key":"2435_CR6","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1093\/carcin\/bgp127","volume":"30","author":"F Colotta","year":"2009","unstructured":"Colotta F, Allavena P, Sica A, Garlanda C, Mantovani A (2009) Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability. Carcinogenesis 30:1073\u20131081. https:\/\/doi.org\/10.1093\/carcin\/bgp127","journal-title":"Carcinogenesis"},{"key":"2435_CR7","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1038\/bjc.1994.294","volume":"70","author":"L Pusztai","year":"1994","unstructured":"Pusztai L, Clover LM, Cooper K, Starkey PM, Lewis CE, McGee JO (1994) Expression of tumour necrosis factor alpha and its receptors in carcinoma of the breast. Br J Cancer 70:289\u2013292","journal-title":"Br J Cancer"},{"key":"2435_CR8","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1111\/j.1349-7006.2006.00277.x","volume":"97","author":"I Garcia-Tunon","year":"2006","unstructured":"Garcia-Tunon I, Ricote M, Ruiz A, Fraile B, Paniagua R, Royuela M (2006) Role of tumor necrosis factor-alpha and its receptors in human benign breast lesions and tumors (in situ and infiltrative). Cancer Sci 97:1044\u20131049. https:\/\/doi.org\/10.1111\/j.1349-7006.2006.00277.x","journal-title":"Cancer Sci"},{"key":"2435_CR9","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.semcancer.2011.12.005","volume":"22","author":"FR Balkwill","year":"2012","unstructured":"Balkwill FR, Mantovani A (2012) Cancer-related inflammation: common themes and therapeutic opportunities. Semin Cancer Biol 22:33\u201340. https:\/\/doi.org\/10.1016\/j.semcancer.2011.12.005","journal-title":"Semin Cancer Biol"},{"key":"2435_CR10","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1186\/s13058-016-0740-2","volume":"18","author":"KM Bussard","year":"2016","unstructured":"Bussard KM, Mutkus L, Stumpf K, Gomez-Manzano C, Marini FC (2016) Tumor-associated stromal cells as key contributors to the tumor microenvironment. Breast Cancer Res 18:84. https:\/\/doi.org\/10.1186\/s13058-016-0740-2","journal-title":"Breast Cancer Res"},{"key":"2435_CR11","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1186\/1471-2407-11-130","volume":"11","author":"G Soria","year":"2011","unstructured":"Soria G, Ofri-Shahak M, Haas I et al (2011) Inflammatory mediators in breast cancer: coordinated expression of TNFalpha & IL-1beta with CCL2 & CCL5 and effects on epithelial-to-mesenchymal transition. BMC Cancer 11:130. https:\/\/doi.org\/10.1186\/1471-2407-11-130","journal-title":"BMC Cancer"},{"key":"2435_CR12","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1002\/jlb.65.3.291","volume":"65","author":"KA Roebuck","year":"1999","unstructured":"Roebuck KA, Carpenter LR, Lakshminarayanan V, Page SM, Moy JN, Thomas LL (1999) Stimulus-specific regulation of chemokine expression involves differential activation of the redox-responsive transcription factors AP-1 and NF-kappaB. J Leukoc Biol 65:291\u2013298","journal-title":"J Leukoc Biol"},{"key":"2435_CR13","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1593\/neo.131688","volume":"15","author":"T Leibovich-Rivkin","year":"2013","unstructured":"Leibovich-Rivkin T, Liubomirski Y, Bernstein B, Meshel T, Ben-Baruch A (2013) Inflammatory factors of the tumor microenvironment induce plasticity in nontransformed breast epithelial cells: EMT, invasion, and collapse of normally organized breast textures. Neoplasia 15:1330\u20131346. https:\/\/doi.org\/10.1593\/neo.131688","journal-title":"Neoplasia"},{"key":"2435_CR14","doi-asserted-by":"publisher","first-page":"720536","DOI":"10.1155\/2013\/720536","volume":"2013","author":"P Weitzenfeld","year":"2013","unstructured":"Weitzenfeld P, Meron N, Leibovich-Rivkin T, Meshel T, Ben-Baruch A (2013) Progression of luminal breast tumors is promoted by menage a trois between the inflammatory cytokine TNFalpha and the hormonal and growth-supporting arms of the tumor microenvironment. Mediat Inflamm 2013:720536. https:\/\/doi.org\/10.1155\/2013\/720536","journal-title":"Mediat Inflamm"},{"key":"2435_CR15","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1186\/1471-2407-14-158","volume":"14","author":"T Leibovich-Rivkin","year":"2014","unstructured":"Leibovich-Rivkin T, Liubomirski Y, Meshel T, Abashidze A, Brisker D, Solomon H, Rotter V, Weil M, Ben-Baruch A (2014) The inflammatory cytokine TNFalpha cooperates with Ras in elevating metastasis and turns WT-Ras to a tumor-promoting entity in MCF-7 cells. BMC Cancer 14:158. https:\/\/doi.org\/10.1186\/1471-2407-14-158","journal-title":"BMC Cancer"},{"key":"2435_CR16","doi-asserted-by":"publisher","first-page":"479","DOI":"10.3389\/fimmu.2017.00479","volume":"8","author":"S Lerrer","year":"2017","unstructured":"Lerrer S, Liubomirski Y, Bott A et al (2017) Co-inflammatory roles of TGFbeta1 in the presence of TNFalpha drive a pro-inflammatory fate in mesenchymal stem cells. Front Immunol 8:479. https:\/\/doi.org\/10.3389\/fimmu.2017.00479","journal-title":"Front Immunol"},{"key":"2435_CR17","doi-asserted-by":"publisher","first-page":"757","DOI":"10.3389\/fimmu.2019.00757","volume":"10","author":"Y Liubomirski","year":"2019","unstructured":"Liubomirski Y, Lerrer S, Meshel T, Rubinstein-Achiasaf L, Morein D, Wiemann S, Korner C, Ben-Baruch A (2019) Tumor-stroma-inflammation networks promote pro-metastatic chemokines and aggressiveness characteristics in triple-negative breast cancer. Front Immunol 10:757. https:\/\/doi.org\/10.3389\/fimmu.2019.00757","journal-title":"Front Immunol"},{"key":"2435_CR18","doi-asserted-by":"publisher","first-page":"804","DOI":"10.3389\/fimmu.2019.00804","volume":"10","author":"Y Liubomirski","year":"2019","unstructured":"Liubomirski Y, Lerrer S, Meshel T et al (2019) Notch-mediated tumor-stroma-inflammation networks promote invasive properties and CXCL8 expression in triple-negative breast cancer. Front Immunol 10:804. https:\/\/doi.org\/10.3389\/fimmu.2019.00804","journal-title":"Front Immunol"},{"key":"2435_CR19","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.ctrv.2017.08.004","volume":"60","author":"C Alfaro","year":"2017","unstructured":"Alfaro C, Sanmamed MF, Rodriguez-Ruiz ME et al (2017) Interleukin-8 in cancer pathogenesis, treatment and follow-up. Cancer Treat Rev 60:24\u201331. https:\/\/doi.org\/10.1016\/j.ctrv.2017.08.004","journal-title":"Cancer Treat Rev"},{"key":"2435_CR20","doi-asserted-by":"publisher","first-page":"28697","DOI":"10.18632\/oncotarget.7376","volume":"7","author":"SY Lim","year":"2016","unstructured":"Lim SY, Yuzhalin AE, Gordon-Weeks AN, Muschel RJ (2016) Targeting the CCL2-CCR2 signaling axis in cancer metastasis. Oncotarget 7:28697\u201328710. https:\/\/doi.org\/10.18632\/oncotarget.7376","journal-title":"Oncotarget"},{"key":"2435_CR21","doi-asserted-by":"publisher","first-page":"292376","DOI":"10.1155\/2014\/292376","volume":"2014","author":"D Aldinucci","year":"2014","unstructured":"Aldinucci D, Colombatti A (2014) The inflammatory chemokine CCL5 and cancer progression. Mediat Inflamm 2014:292376. https:\/\/doi.org\/10.1155\/2014\/292376","journal-title":"Mediat Inflamm"},{"key":"2435_CR22","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/j.cytogfr.2014.07.016","volume":"25","author":"LM Sedger","year":"2014","unstructured":"Sedger LM, McDermott MF (2014) TNF and TNF-receptors: from mediators of cell death and inflammation to therapeutic giants - past, present and future. Cytokine Growth Factor Rev 25:453\u2013472. https:\/\/doi.org\/10.1016\/j.cytogfr.2014.07.016","journal-title":"Cytokine Growth Factor Rev"},{"key":"2435_CR23","doi-asserted-by":"publisher","first-page":"6313242","DOI":"10.1155\/2019\/6313242","volume":"2019","author":"MAI Al-Hatamleh","year":"2019","unstructured":"Al-Hatamleh MAI, Ahmad S, Boer JC, Lim J, Chen X, Plebanski M, Mohamud R (2019) A perspective review on the role of nanomedicine in the modulation of TNF-TNFR2 axis in breast cancer immunotherapy. J Oncol 2019:6313242. https:\/\/doi.org\/10.1155\/2019\/6313242","journal-title":"J Oncol"},{"key":"2435_CR24","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1007\/s12307-011-0094-3","volume":"5","author":"A Ben-Baruch","year":"2012","unstructured":"Ben-Baruch A (2012) The tumor-promoting flow of cells into, within and out of the tumor site: regulation by the inflammatory axis of TNFalpha and chemokines. Cancer Microenviron 5:151\u2013164. https:\/\/doi.org\/10.1007\/s12307-011-0094-3","journal-title":"Cancer Microenviron"},{"key":"2435_CR25","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1016\/j.bbrc.2011.03.051","volume":"407","author":"T Hamaguchi","year":"2011","unstructured":"Hamaguchi T, Wakabayashi H, Matsumine A, Sudo A, Uchida A (2011) TNF inhibitor suppresses bone metastasis in a breast cancer cell line. Biochem Biophys Res Commun 407:525\u2013530. https:\/\/doi.org\/10.1016\/j.bbrc.2011.03.051","journal-title":"Biochem Biophys Res Commun"},{"key":"2435_CR26","doi-asserted-by":"publisher","first-page":"2655","DOI":"10.1158\/1535-7163.mct-09-0358","volume":"8","author":"MA Warren","year":"2009","unstructured":"Warren MA, Shoemaker SF, Shealy DJ, Bshar W, Ip MM (2009) Tumor necrosis factor deficiency inhibits mammary tumorigenesis and a tumor necrosis factor neutralizing antibody decreases mammary tumor growth in neu\/erbB2 transgenic mice. Mol Cancer Ther 8:2655\u20132663. https:\/\/doi.org\/10.1158\/1535-7163.mct-09-0358","journal-title":"Mol Cancer Ther"},{"key":"2435_CR27","doi-asserted-by":"publisher","first-page":"4061","DOI":"10.1158\/0008-5472.CAN-12-3946","volume":"73","author":"M Yu","year":"2013","unstructured":"Yu M, Zhou X, Niu L et al (2013) Targeting transmembrane TNF-alpha suppresses breast cancer growth. Cancer Res 73:4061\u20134074. https:\/\/doi.org\/10.1158\/0008-5472.CAN-12-3946","journal-title":"Cancer Res"},{"key":"2435_CR28","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1038\/sj.onc.1209176","volume":"25","author":"MF Rubio","year":"2006","unstructured":"Rubio MF, Werbajh S, Cafferata EG, Quaglino A, Colo GP, Nojek IM, Kordon EC, Nahmod VE, Costas MA (2006) TNF-alpha enhances estrogen-induced cell proliferation of estrogen-dependent breast tumor cells through a complex containing nuclear factor-kappa B. Oncogene 25:1367\u20131377. https:\/\/doi.org\/10.1038\/sj.onc.1209176","journal-title":"Oncogene"},{"key":"2435_CR29","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1007\/s10549-009-0546-3","volume":"122","author":"MA Rivas","year":"2009","unstructured":"Rivas MA, Tkach M, Beguelin W, Proietti CJ, Rosemblit C, Charreau EH, Elizalde PV, Schillaci R (2009) Transactivation of ErbB-2 induced by tumor necrosis factor alpha promotes NF-kappaB activation and breast cancer cell proliferation. Breast Cancer Res Treat 122:111\u2013124. https:\/\/doi.org\/10.1007\/s10549-009-0546-3","journal-title":"Breast Cancer Res Treat"},{"key":"2435_CR30","doi-asserted-by":"publisher","first-page":"5068","DOI":"10.1074\/jbc.M115.702571","volume":"291","author":"Y Qiao","year":"2016","unstructured":"Qiao Y, He H, Jonsson P, Sinha I, Zhao C, Dahlman-Wright K (2016) AP-1 is a key regulator of proinflammatory cytokine TNFalpha-mediated triple-negative breast cancer progression. J Biol Chem 291:5068\u20135079. https:\/\/doi.org\/10.1074\/jbc.M115.702571","journal-title":"J Biol Chem"},{"key":"2435_CR31","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1016\/j.ctrv.2011.11.005","volume":"38","author":"P Eroles","year":"2012","unstructured":"Eroles P, Bosch A, Perez-Fidalgo JA, Lluch A (2012) Molecular biology in breast cancer: intrinsic subtypes and signaling pathways. Cancer Treat Rev 38:698\u2013707. https:\/\/doi.org\/10.1016\/j.ctrv.2011.11.005","journal-title":"Cancer Treat Rev"},{"key":"2435_CR32","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1016\/j.mce.2013.06.003","volume":"382","author":"X Jiang","year":"2014","unstructured":"Jiang X, Shapiro DJ (2014) The immune system and inflammation in breast cancer. Mol Cell Endocrinol 382:673\u2013682. https:\/\/doi.org\/10.1016\/j.mce.2013.06.003","journal-title":"Mol Cell Endocrinol"},{"key":"2435_CR33","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1111\/imr.12614","volume":"281","author":"A Mantovani","year":"2018","unstructured":"Mantovani A, Barajon I, Garlanda C (2018) IL-1 and IL-1 regulatory pathways in cancer progression and therapy. Immunol Rev 281:57\u201361. https:\/\/doi.org\/10.1111\/imr.12614","journal-title":"Immunol Rev"},{"key":"2435_CR34","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1002\/ijc.2910560603","volume":"56","author":"DW Miles","year":"1994","unstructured":"Miles DW, Happerfield LC, Naylor MS, Bobrow LG, Rubens RD, Balkwill FR (1994) Expression of tumour necrosis factor (TNF alpha) and its receptors in benign and malignant breast tissue. Int J Cancer 56:777\u2013782","journal-title":"Int J Cancer"},{"key":"2435_CR35","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1038\/nrc3396","volume":"13","author":"G Deblois","year":"2013","unstructured":"Deblois G, Giguere V (2013) Oestrogen-related receptors in breast cancer: control of cellular metabolism and beyond. Nat Rev Cancer 13:27\u201336. https:\/\/doi.org\/10.1038\/nrc3396","journal-title":"Nat Rev Cancer"},{"key":"2435_CR36","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1189\/jlb.3MA0815-373R","volume":"99","author":"P Weitzenfeld","year":"2016","unstructured":"Weitzenfeld P, Kossover O, Korner C, Meshel T, Wiemann S, Seliktar D, Legler DF, Ben-Baruch A (2016) Chemokine axes in breast cancer: factors of the tumor microenvironment reshape the CCR7-driven metastatic spread of luminal-A breast tumors. J Leukoc Biol 99:1009\u20131025. https:\/\/doi.org\/10.1189\/jlb.3MA0815-373R","journal-title":"J Leukoc Biol"},{"key":"2435_CR37","doi-asserted-by":"publisher","first-page":"81123","DOI":"10.18632\/oncotarget.13213","volume":"7","author":"P Weitzenfeld","year":"2016","unstructured":"Weitzenfeld P, Meshel T, Ben-Baruch A (2016) Microenvironmental networks promote tumor heterogeneity and enrich for metastatic cancer stem-like cells in Luminal-A breast tumor cells. Oncotarget 7:81123\u201381143. https:\/\/doi.org\/10.18632\/oncotarget.13213","journal-title":"Oncotarget"},{"key":"2435_CR38","doi-asserted-by":"publisher","first-page":"R87","DOI":"10.1186\/bcr2944","volume":"13","author":"H Sihto","year":"2011","unstructured":"Sihto H, Lundin J, Lundin M et al (2011) Breast cancer biological subtypes and protein expression predict for the preferential distant metastasis sites: a nationwide cohort study. Breast Cancer Res 13:R87. https:\/\/doi.org\/10.1186\/bcr2944","journal-title":"Breast Cancer Res"},{"key":"2435_CR39","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1038\/nrc.2016.73","volume":"16","author":"R Kalluri","year":"2016","unstructured":"Kalluri R (2016) The biology and function of fibroblasts in cancer. Nat Rev Cancer 16:582\u2013598. https:\/\/doi.org\/10.1038\/nrc.2016.73","journal-title":"Nat Rev Cancer"},{"key":"2435_CR40","doi-asserted-by":"publisher","first-page":"220","DOI":"10.4161\/cam.20875","volume":"6","author":"BG Cuiffo","year":"2012","unstructured":"Cuiffo BG, Karnoub AE (2012) Mesenchymal stem cells in tumor development: emerging roles and concepts. Cell Adh Migr 6:220\u2013230. https:\/\/doi.org\/10.4161\/cam.20875","journal-title":"Cell Adh Migr"},{"key":"2435_CR41","doi-asserted-by":"publisher","first-page":"10044","DOI":"10.1158\/0008-5472.CAN-10-1254","volume":"70","author":"RH Goldstein","year":"2010","unstructured":"Goldstein RH, Reagan MR, Anderson K, Kaplan DL, Rosenblatt M (2010) Human bone marrow-derived MSCs can home to orthotopic breast cancer tumors and promote bone metastasis. Cancer Res 70:10044\u201310050. https:\/\/doi.org\/10.1158\/0008-5472.CAN-10-1254","journal-title":"Cancer Res"},{"key":"2435_CR42","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1038\/nature06188","volume":"449","author":"AE Karnoub","year":"2007","unstructured":"Karnoub AE, Dash AB, Vo AP et al (2007) Mesenchymal stem cells within tumour stroma promote breast cancer metastasis. Nature 449:557\u2013563. https:\/\/doi.org\/10.1038\/nature06188","journal-title":"Nature"},{"key":"2435_CR43","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1016\/j.immuni.2019.03.024","volume":"50","author":"E Batlle","year":"2019","unstructured":"Batlle E, Massague J (2019) Transforming growth factor-beta signaling in immunity and cancer. Immunity 50:924\u2013940. https:\/\/doi.org\/10.1016\/j.immuni.2019.03.024","journal-title":"Immunity"},{"key":"2435_CR44","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1007\/s10555-018-9741-1","volume":"37","author":"S Umamaheswaran","year":"2018","unstructured":"Umamaheswaran S, Dasari SK, Yang P, Lutgendorf SK, Sood AK (2018) Stress, inflammation, and eicosanoids: an emerging perspective. Cancer Metastasis Rev 37:203\u2013211. https:\/\/doi.org\/10.1007\/s10555-018-9741-1","journal-title":"Cancer Metastasis Rev"},{"key":"2435_CR45","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.nbt.2017.08.004","volume":"39","author":"M Lamy","year":"2017","unstructured":"Lamy M, Ferreira A, Dias JS, Braga S, Silva G, Barbas A (2017) Notch-out for breast cancer therapies. N Biotechnol 39:215\u2013221. https:\/\/doi.org\/10.1016\/j.nbt.2017.08.004","journal-title":"N Biotechnol"},{"key":"2435_CR46","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1186\/s13287-015-0080-7","volume":"6","author":"C Katanov","year":"2015","unstructured":"Katanov C, Lerrer S, Liubomirski Y et al (2015) Regulation of the inflammatory profile of stromal cells in human breast cancer: prominent roles for TNF-alpha and the NF-kappaB pathway. Stem Cell Res Ther 6:87. https:\/\/doi.org\/10.1186\/s13287-015-0080-7","journal-title":"Stem Cell Res Ther"},{"key":"2435_CR47","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1158\/0008-5472.CAN-16-0442","volume":"77","author":"R Li","year":"2017","unstructured":"Li R, Hebert JD, Lee TA, Xing H, Boussommier-Calleja A, Hynes RO, Lauffenburger DA, Kamm RD (2017) Macrophage-secreted TNFalpha and TGFbeta1 influence migration speed and persistence of cancer cells in 3D tissue culture via independent pathways. Cancer Res 77:279\u2013290. https:\/\/doi.org\/10.1158\/0008-5472.CAN-16-0442","journal-title":"Cancer Res"},{"key":"2435_CR48","doi-asserted-by":"publisher","first-page":"e43272","DOI":"10.1371\/journal.pone.0043272","volume":"7","author":"Y Jing","year":"2012","unstructured":"Jing Y, Han Z, Liu Y et al (2012) Mesenchymal stem cells in inflammation microenvironment accelerates hepatocellular carcinoma metastasis by inducing epithelial-mesenchymal transition. PLoS One 7:e43272. https:\/\/doi.org\/10.1371\/journal.pone.0043272","journal-title":"PLoS One"},{"key":"2435_CR49","doi-asserted-by":"publisher","first-page":"25007","DOI":"10.1074\/jbc.M110.213108","volume":"286","author":"Y Liu","year":"2011","unstructured":"Liu Y, Han ZP, Zhang SS et al (2011) Effects of inflammatory factors on mesenchymal stem cells and their role in the promotion of tumor angiogenesis in colon cancer. J Biol Chem 286:25007\u201325015. https:\/\/doi.org\/10.1074\/jbc.M110.213108","journal-title":"J Biol Chem"},{"key":"2435_CR50","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.stem.2007.11.014","volume":"2","author":"G Ren","year":"2008","unstructured":"Ren G, Zhang L, Zhao X, Xu G, Zhang Y, Roberts AI, Zhao RC, Shi Y (2008) Mesenchymal stem cell-mediated immunosuppression occurs via concerted action of chemokines and nitric oxide. Cell Stem Cell 2:141\u2013150. https:\/\/doi.org\/10.1016\/j.stem.2007.11.014","journal-title":"Cell Stem Cell"},{"key":"2435_CR51","doi-asserted-by":"publisher","first-page":"24354","DOI":"10.1038\/srep24354","volume":"6","author":"P De Marco","year":"2016","unstructured":"De Marco P, Lappano R, De Francesco EM et al (2016) GPER signalling in both cancer-associated fibroblasts and breast cancer cells mediates a feedforward IL1beta\/IL1R1 response. Sci Rep 6:24354. https:\/\/doi.org\/10.1038\/srep24354","journal-title":"Sci Rep"},{"key":"2435_CR52","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1593\/neo.121228","volume":"15","author":"IG Schauer","year":"2013","unstructured":"Schauer IG, Zhang J, Xing Z, Guo X, Mercado-Uribe I, Sood AK, Huang P, Liu J (2013) Interleukin-1beta promotes ovarian tumorigenesis through a p53\/NF-kappaB-mediated inflammatory response in stromal fibroblasts. Neoplasia 15:409\u2013420. https:\/\/doi.org\/10.1593\/neo.121228","journal-title":"Neoplasia"},{"key":"2435_CR53","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1158\/2159-8290.cd-12-0101","volume":"2","author":"HJ Li","year":"2012","unstructured":"Li HJ, Reinhardt F, Herschman HR, Weinberg RA (2012) Cancer-stimulated mesenchymal stem cells create a carcinoma stem cell niche via prostaglandin E2 signaling. Cancer Discov 2:840\u2013855. https:\/\/doi.org\/10.1158\/2159-8290.cd-12-0101","journal-title":"Cancer Discov"}],"container-title":["Cancer Immunology, Immunotherapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00262-019-02435-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00262-019-02435-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00262-019-02435-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,8]],"date-time":"2020-12-08T01:19:29Z","timestamp":1607390369000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00262-019-02435-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12,9]]},"references-count":53,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,2]]}},"alternative-id":["2435"],"URL":"https:\/\/doi.org\/10.1007\/s00262-019-02435-4","relation":{},"ISSN":["0340-7004","1432-0851"],"issn-type":[{"value":"0340-7004","type":"print"},{"value":"1432-0851","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12,9]]},"assertion":[{"value":"5 August 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 November 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 December 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The author declares no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}